{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:55:18Z","timestamp":1773381318852,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016387","name":"Grifols SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ymgmr.2026.101295","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:17:05Z","timestamp":1770970625000},"page":"101295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical implications of a novel SERPINA1 variant c.236\u00a0T\u00a0&gt;\u00a0A: Challenges in characterizing new rare alpha-1 antitrypsin mutations"],"prefix":"10.1016","volume":"46","author":[{"given":"Arturo","family":"Olivares-Rivera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilal","family":"Ers\u00f6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"H\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Veith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timm","family":"Greulich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Schlamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Janciauskiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Herth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska C.","family":"Trudzinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2026.101295_bb0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.rmed.2016.06.005","article-title":"Novel variants of SERPIN1A gene: interplay between alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease","volume":"117","author":"Bashir","year":"2016","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101295_bb0010","first-page":"677","article-title":"Alpha1-antitrypsin","volume":"25","author":"Kueppers","year":"1973","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.ymgmr.2026.101295_bb0015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1515\/znb-1955-0810","article-title":"Zur Kenntnis der \u03b1-Globuline des menschlichen Normalserums","volume":"10","author":"Schultze","year":"1955","journal-title":"Zeitschrift f\u00fcr Naturforschung B"},{"issue":"9","key":"10.1016\/j.ymgmr.2026.101295_bb0020","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1016\/S0021-9258(19)85615-6","article-title":"Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin","volume":"255","author":"Beatty","year":"1980","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101295_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09031936.03.00063703","article-title":"Global strategy for the diagnosis, management and prevention of COPD: 2003 update","volume":"22","author":"Fabbri","year":"2003","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.ymgmr.2026.101295_bb0030","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1172\/JCI110344","article-title":"Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema","volume":"68","author":"Gadek","year":"1981","journal-title":"J. Clin. Invest."},{"issue":"5482","key":"10.1016\/j.ymgmr.2026.101295_bb0035","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1126\/science.289.5482.1185","article-title":"Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase","volume":"289","author":"Belaaouaj","year":"2000","journal-title":"Science"},{"issue":"6878","key":"10.1016\/j.ymgmr.2026.101295_bb0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/416291a","article-title":"Killing activity of neutrophils is mediated through activation of proteases by K+ flux","volume":"416","author":"Reeves","year":"2002","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.ymgmr.2026.101295_bb0045","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM198910053211402","article-title":"The effect of cigarette smoking on neutrophil kinetics in human lungs","volume":"321","author":"MacNee","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2026.101295_bb0050","series-title":"Alpha-1 Antitrypsin. Respiratory Medicine","article-title":"Alpha-1 antitrypsin: the protein","author":"Lussier","year":"2016"},{"key":"10.1016\/j.ymgmr.2026.101295_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1443297","article-title":"Immunological and homeostatic pathways of alpha \u22121 antitrypsin: a new therapeutic potential","volume":"15","author":"Mazzuca","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymgmr.2026.101295_bb0060","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2025.13472","article-title":"Alpha-1 antitrypsin is a potential target of inflammation and immunomodulation (review)","volume":"31","author":"Wang","year":"2025","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101295_bb0065","first-page":"71","article-title":"What we Owe to \u03b11-antitrypsin and to Carl-Bertil Laurell","volume":"1","author":"Carrell","year":"2004","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"issue":"sup1","key":"10.1016\/j.ymgmr.2026.101295_bb0070","first-page":"3","article-title":"The electrophoretic \u03b11-globulin pattern of serum in \u03b11-antitrypsin deficiency","volume":"10","author":"Laurell","year":"2013","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101295_bb0075","first-page":"934","article-title":"Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder","volume":"73","author":"Sharp","year":"1969","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ymgmr.2026.101295_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-2797(85)80161-7","article-title":"Mechanisms of cigarette smoke toxicity: the inactivation of human \u03b1-1-proteinase inhibitor by nitric oxide\/isoprene mixtures in air","volume":"54","author":"Pryor","year":"1985","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101295_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1753465811434320","article-title":"Rare alpha-1-antitrypsin variants: are they really so rare?","volume":"6","author":"Rodriguez-Frias","year":"2012","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101295_bb0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13023-024-03069-1","article-title":"Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review","volume":"19","author":"Ferrarotti","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101295_bb0095","first-page":"7","article-title":"Novel SERPINA1 alleles identified through a large alpha-1 antitrypsin deficiency screening program and review of known variants","volume":"10","author":"Wiesemann","year":"2023","journal-title":"Chron. Obstruct. Pulmon. Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101295_bb0100","doi-asserted-by":"crossref","DOI":"10.1080\/25310429.2024.2429911","article-title":"Clinical features in patients with severe alpha-1 antitrypsin deficiency due to rare genotypes","volume":"31","author":"Ferrarotti","year":"2024","journal-title":"Pulmonology"},{"issue":"11","key":"10.1016\/j.ymgmr.2026.101295_bb0105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jmoldx.2024.08.002","article-title":"Haplotype-aware detection of SERPINA1 variants by nanopore sequencing","volume":"26","author":"Gonz\u00e1lez-Carracedo","year":"2024","journal-title":"J. Mol. Diagn."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101295_bb0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajcp\/aqw112","article-title":"A library of rare \u03b11-antitrypsin (AAT) variant phenotypes to aid in the diagnosis of AAT deficiency","volume":"146","author":"Akbas","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"issue":"17","key":"10.1016\/j.ymgmr.2026.101295_bb0115","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.3390\/ijms23179859","article-title":"Improving the laboratory diagnosis of M-like variants related to alpha1-antitrypsin deficiency","volume":"23","author":"Barzon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2026.101295_bb0120","series-title":"Alpha-1 Antitrypsin. Respiratory Medicine","article-title":"Misfolding and polymerisation of alpha1-antitrypsin: conformational pathology and therapeutic targeting","author":"Gooptu","year":"2016"},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101295_bb0125","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1513\/pats.201004-031AW","article-title":"The folding pathway of alpha1-antitrypsin: avoiding the unavoidable","volume":"7","author":"Bottomley","year":"2010","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101295_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054766","article-title":"The roles of helix I and Strand 5A in the folding, function and misfolding of \u03b11-antitrypsin","volume":"8","author":"Knaupp","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101295_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038405","article-title":"Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization","volume":"7","author":"Fra","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2026.101295_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2017.07.004","article-title":"Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ","volume":"130","author":"Bernhard","year":"2017","journal-title":"Respir. Med."},{"issue":"10","key":"10.1016\/j.ymgmr.2026.101295_bb0145","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thoraxjnl-2015-206906","article-title":"PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD","volume":"70","author":"Green","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.ymgmr.2026.101295_bb0150","doi-asserted-by":"crossref","DOI":"10.1177\/2040622321995684","article-title":"Liver disease with unknown etiology \u2013 have you ruled out alpha-1 antitrypsin deficiency?","volume":"12_suppl","author":"Patel","year":"2021","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"14","key":"10.1016\/j.ymgmr.2026.101295_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/TACG.S257511","article-title":"Known mutations at the cause of alpha-1 antitrypsin deficiency an updated overview of SERPINA1 variation spectrum","volume":"22","author":"Seixas","year":"2021","journal-title":"Appl. Clin. Genet."},{"issue":"15","key":"10.1016\/j.ymgmr.2026.101295_bb0160","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.194354","article-title":"Susceptibility of alpha-1 antitrypsin deficiency variants to polymer-blocking therapy","volume":"10","author":"Ronzoni","year":"2025","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.ymgmr.2026.101295_bb0165","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1164\/rccm.202305-0863OC","article-title":"Augmentation therapy for severe alpha-1 antitrypsin deficiency improves survival and is decoupled from spirometric decline-a multinational registry analysis","volume":"208","author":"Fraughen","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101295_bb0170","first-page":"668","article-title":"The diagnosis and management of alpha-1 antitrypsin deficiency in the adult","volume":"3","author":"Sandhaus","year":"2016","journal-title":"Chron. Obstruct. Pulmon. Dis. (Miami, Fla.)"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:43:03Z","timestamp":1773355383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426926000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"alternative-id":["S2214426926000078"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101295","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical implications of a novel SERPINA1 variant c.236\u00a0T\u00a0>\u00a0A: Challenges in characterizing new rare alpha-1 antitrypsin mutations","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101295"}}